What is Medidata Solutions' stock symbol?
Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."
Where is Medidata Solutions' stock going? Where will Medidata Solutions' stock price be in 2017?
11 brokers have issued 1 year target prices for Medidata Solutions' stock. Their predictions range from $47.00 to $70.00. On average, they anticipate Medidata Solutions' stock price to reach $57.40 in the next year.
When will Medidata Solutions announce their earnings?
Medidata Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, April, 19th 2017.
What are analysts saying about Medidata Solutions stock?
Here are some recent quotes from research analysts about Medidata Solutions stock:
According to Zacks Investment Research, "Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies. " (2/15/2017)
- Jefferies Group LLC analysts commented, "Based on several triangulations, FY17 revenue guidance appears to mark a very accurate target at the midpoint (not too high or low). The 18.7% midpoint growth would need to further accelerate to 22% in '18-'20 to achieve management's $1B goal by '20. Beating the '16 sales performance seems like a tall order. MDSO now trades at 5.6x '17 revenue compared to 4.4x for SaaS peers with similar growth." (2/10/2017)
Who owns Medidata Solutions stock?
Medidata Solutions' stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (13.60%), Brown Capital Management LLC (10.57%), Sands Capital Management LLC (6.80%), Champlain Investment Partners LLC (2.66%), State Street Corp (2.19%) and Fred Alger Management Inc. (1.77%). Company insiders that own Medidata Solutions stock include Cory Douglas, Eileen Schloss, Lee Shapiro, Michael I Otner, Michael L Capone, Neil M Kurtz, Robert Taylor, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De.
Who sold Medidata Solutions stock? Who is selling Medidata Solutions stock?
Medidata Solutions' stock was sold by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Frontier Capital Management Co. LLC, Fiera Capital Corp, Janus Capital Management LLC, Sands Capital Management LLC, Columbia Wanger Asset Management LLC, Castleark Management LLC and Oxford Asset Management. Company insiders that have sold Medidata Solutions stock in the last year include Eileen Schloss, Michael I Otner, Michael L Capone, Neil M Kurtz, Robert Taylor, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De.
Who bought Medidata Solutions stock? Who is buying Medidata Solutions stock?
Medidata Solutions' stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Fred Alger Management Inc., Arrowpoint Asset Management LLC, Ranger Investment Management L.P., Renaissance Technologies LLC, State Street Corp, Brown Advisory Inc. and Russell Investments Group Ltd..
How do I buy Medidata Solutions stock?
Shares of Medidata Solutions can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Medidata Solutions stock cost?
One share of Medidata Solutions stock can currently be purchased for approximately $56.10.